Showing results 1 to 4 of 4
An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases Kim, Dong Wook; Jo, Young Suk; Jung, Hye Sook; Chung, Hyo Kyun; Song, Jung Hun; Park, Ki Cheol; Park, Su Hyeon; et al, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, v.91, no.10, pp.4070 - 4076, 2006-10 |
CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its rransactivation Park, Ki Cheol; Song, Kwang Hoon; Chung, Hyo Kyun; Kim, Ho; Kim, Dong Wook; Song, Jung Hun; Hwang, Eun Suk; et al, MOLECULAR ENDOCRINOLOGY, v.19, no.1, pp.12 - 24, 2005-01 |
Regulation of protein kinase B tyrosine phosphorylation by thyroid-specific oncogenic RET/PTC kinases Jung, Hye Sook; Kim, Dong Wook; Jo, Young Suk; Chung, Hyo Kyun; Song, Jung Hun; Park, Jong Sun; Park, Ki Cheol; et al, MOLECULAR ENDOCRINOLOGY, v.19, no.11, pp.2748 - 2759, 2005-11 |
Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases Hwang, Eun Suk; Kim, Dong Wook; Hwang, Jung Hwan; Jung, Hye Sook; Suh, Jae Mi; Park, Young Joo; Chung, Hyo Kyun; et al, MOLECULAR ENDOCRINOLOGY, v.18, no.11, pp.2672 - 2684, 2004-11 |
Discover